Mazdeh, M., Hosseini, S., Taheri, M., & Ghafouri‐Fard, S. (2018). The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: A prospective cohort study. Clinical & Translational Medicine, 7(1), 1. https://doi.org/10.1186/s40169-018-0216-3
Chicago Style (17th ed.) CitationMazdeh, Mehrdokht, Shno Hosseini, Mohammad Taheri, and Soudeh Ghafouri‐Fard. "The Effect of Natalizumab on Disability Score and Relapse Rate of Multiple Sclerosis Patients: A Prospective Cohort Study." Clinical & Translational Medicine 7, no. 1 (2018): 1. https://doi.org/10.1186/s40169-018-0216-3.
MLA (9th ed.) CitationMazdeh, Mehrdokht, et al. "The Effect of Natalizumab on Disability Score and Relapse Rate of Multiple Sclerosis Patients: A Prospective Cohort Study." Clinical & Translational Medicine, vol. 7, no. 1, 2018, p. 1, https://doi.org/10.1186/s40169-018-0216-3.